U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114055) titled 'Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome' on July 08.
Brief Summary: The goal of this clinical trial is to assess and compare the effect of ebastine and placebo in improving symptoms in patients with diarrhea predominant IBS. It will also assess about the safety of drugs ebastine and placebo by recording the patient reported adverse events. The main questions it aim to answer are:
Does drug ebastine and placebo has any effect on patients with IBS-D? What medical problems do participants have when taking drug ebastine and placebo? Researcher will compare effect of drug ebastine and placebo ....